APA (7th ed.) Citation

J, M., CC, B., J, J., LM, S., A, M., D, K., . . . S, Z. (2022). Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021. MMWR. Morbidity and mortality weekly report, 71(24), 786. https://doi.org/10.15585/mmwr.mm7124a2

Chicago Style (17th ed.) Citation

J, Martin, et al. "Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021." MMWR. Morbidity and Mortality Weekly Report 71, no. 24 (2022): 786. https://doi.org/10.15585/mmwr.mm7124a2.

MLA (9th ed.) Citation

J, Martin, et al. "Genetic Characterization of Novel Oral Polio Vaccine Type 2 Viruses During Initial Use Phase Under Emergency Use Listing - Worldwide, March-October 2021." MMWR. Morbidity and Mortality Weekly Report, vol. 71, no. 24, 2022, p. 786, https://doi.org/10.15585/mmwr.mm7124a2.